share_log

Meinian Onehealth Healthcare Holdings (SZSE:002044) Stock Falls 4.4% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend

Meinian Onehealth Healthcare Holdings (SZSE:002044) Stock Falls 4.4% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend

美年健康(SZSE:002044)股票上周下跌4.4%,五年收益和股东回报持续下降趋势。
Simply Wall St ·  06/24 10:18

Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. For example, after five long years the Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) share price is a whole 62% lower. We certainly feel for shareholders who bought near the top. And some of the more recent buyers are probably worried, too, with the stock falling 41% in the last year. The falls have accelerated recently, with the share price down 23% in the last three months.

总体而言,长期投资是值得的,但是在路上有些股票会表现不佳。例如,五年后,美年健康(股票代码:SZSE:002044)的股价已经下跌了整整62%。我们确实为那些接近买入高点的股东感到难过。而一些更近期的买家也可能感到担忧,股价在过去一年中下跌了41%。最近跌势加速,股价在过去三个月下跌了23%。

Since Meinian Onehealth Healthcare Holdings has shed CN¥700m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.

由于在过去7天中,美年健康(股票代码:SZSE:002044)市值已减少了7亿元,让我们看看长期的下跌是否受到业务经济的推动。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

虽然有效市场假说仍然被一些人教授,但被证明市场是过度反应的动态系统,投资者并不总是理性的。检查市场情绪如何随时间变化的一种方法是看一个公司的股价与其每股收益(EPS)之间的交互作用。

Meinian Onehealth Healthcare Holdings became profitable within the last five years. That would generally be considered a positive, so we are surprised to see the share price is down. Other metrics might give us a better handle on how its value is changing over time.

美年健康在过去五年内实现了盈利。这通常被认为是好事,所以我们对股价下跌感到惊讶。其他指标可能能更好地帮我们了解其价值如何随时间变化。

We don't think that the 0.5% is big factor in the share price, since it's quite small, as dividends go. In contrast to the share price, revenue has actually increased by 5.5% a year in the five year period. So it seems one might have to take closer look at the fundamentals to understand why the share price languishes. After all, there may be an opportunity.

我们认为0.5%对于股价来说不是很重要,因为它相当小,与股息相比。相比股价,营业收入实际上在过去五年中年增长5.5%。所以看起来必须更仔细地了解基本面才能理解为什么股价疲软。毕竟,可能存在机会。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

你可以在下面的图片中看到收入和营业收入随时间的变化情况(单击图表可查看精确值)。

earnings-and-revenue-growth
SZSE:002044 Earnings and Revenue Growth June 24th 2024
SZSE:002044盈利和营业收入增长2024年6月24日

We know that Meinian Onehealth Healthcare Holdings has improved its bottom line lately, but what does the future have in store? If you are thinking of buying or selling Meinian Onehealth Healthcare Holdings stock, you should check out this free report showing analyst profit forecasts.

我们知道美年健康(股票代码:SZSE:002044)最近改善了其底线,但未来会怎样?如果您正考虑购买或出售美年健康(股票代码:SZSE:002044),则应查看此免费报告,显示分析师盈利预测。

A Different Perspective

不同的观点

While the broader market lost about 14% in the twelve months, Meinian Onehealth Healthcare Holdings shareholders did even worse, losing 41% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 10% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Before forming an opinion on Meinian Onehealth Healthcare Holdings you might want to consider these 3 valuation metrics.

虽然整个市场在十二个月中损失了约14%,但美年健康(股票代码:SZSE:002044)的股东表现更糟糕,股价下跌了41%(包括股息)。但是,这可能仅是因为股价受到更广泛的市场焦虑的影响。可能值得密切关注基本面,以防出现良好的机会。遗憾的是,去年的表现结束了一段糟糕的时期,股东面临着每年总计10%的亏损。我们意识到Baron Rothschild曾说过投资者应该“在街上流血时购买”,但我们警告投资者首先要确保他们购买的是高质量的公司。在对美年健康(股票代码:SZSE:002044)形成意见之前,您可能要考虑这三个估值指标。

Of course Meinian Onehealth Healthcare Holdings may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

当然,美年健康(股票代码:SZSE:002044)可能不是最好的股票购买对象。因此,您可能希望查看这些增长股的免费收藏。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发